Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q4 FY2024 Earnings Presentation
32 slides from Rossari Biotech's earnings presentation, Apr 30, 2024
Slide 1: Exchange filing cover letter for Q4 FY24 earnings presentation
April 30, 2024 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No.C/1, ‘G’Block, Bandra- Kurla Dalal Street, Fort Mumbai 400 001 Complex Bandra East Mumbai 400 051 Fax
Slide 2: Rossari Biotech Ltd. Q4 & FY24 Results Presentation
Rossari Biotech Ltd. Q4 & FY24 Results Presentation April 29, 2024
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd. (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to
Slide 4: FY24 Results Overview, Company Overview, Annexure
FY24 Results Overview Company Overview Annexure 3
Slide 5: Q4 FY24 – Key Financial Highlights
Q4 FY24 – Key Financial Highlights Strong Quarterly Performance Strong quarterly Revenue Consistent quarterly EBITDA Steady quarterly PAT Revenue from Operations EBITDA PAT Business Sector (Rs. cr) (Rs. cr) (Rs. cr) contribution (Rs. cr) 472.7 AHN, 463.8 63.6 63.7 34.1 34.4 7% 406.5 54.6 29.0 TSC, 2
Slide 6: FY24 – Key Financial Highlights
FY24 – Key Financial Highlights Steady Revenue Growth Highest Annual EBITDA Highest Annual PAT Revenue from Operations EBITDA PAT Business Sector (Rs. cr) (Rs. cr) (Rs. cr) contribution (Rs. cr) 1,8… AHN, 130.7 6% 1,655.9 249.8 223.0 107.3 TSC, 19% FY24 HPPC, 75% FY24 FY23 FY24 FY23 FY24 FY23 Shift
Slide 7: Financial Performance Snapshot
Financial Performance Snapshot Revenue (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) CAGR – 37% CAGR – 26% CAGR – 18% 131 1,830 250 1,656 223 107 1,483 98 185 80 124 709 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 Exports (Rs. cr) ROE (%) ROCE (%) Net Debt to Equity (x) CAGR – 90% 28.0 24.0
Slide 8: Management Message
Management Message Commenting on the Q4 FY24 performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We are pleased to conclude the year on a strong note, with a healthy Y-o-Y increase in revenues and profits, sta
Slide 9: Key Developments
Key Developments Announces annual dividend of Rs. 0.50/- per share For FY 2023-24, the Board of Directors recommended a dividend of Rs. 0.50 /- per share Update on the Capex In a strategic move towards future readiness, in the Q2FY24 the Company had announced an expansion of its facility at Dahe
Slide 10: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. cr) Q4 FY24 Q4 FY23 Y-o-Y FY24 FY23 Y-o-Y Revenues from Operations 472.7 406.5 16.3% 1,830.6 1,655.9 10.6% Total Expenditure •COGS 338.3 286.3 18.2% 1,293.5 1,171.3 10.4% •Employee benefits expense 25.0 26.8 -6.7% 103.1 98.6 4.6% •Other expenses
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet EQUITY AND LIABILITIES ASSETS As on 31st March As on 31st March As on 31st March As on 31st March Particulars (Rs. cr) Particulars (Rs. cr) 2024 (Audited) 2023 (Audited) 2024 (Audited) 2023 (Audited) EQUITY ASSETS Equity Share Capital 11.0 11.0 NON-CURRENT ASSETS Other Equ
Slide 12: Consolidated Cash Flows
Consolidated Cash Flows As on 31st As on 31st As on 31st As on 31st Particulars (Rs. cr) March 2024 March 2023 Particulars (Rs. cr) March 2024 March 2023 (Audited) (Unaudited) (Audited) (Audited) Cash flows from operating activities Cash flows from investing activities Profit before tax 177.6 144.2
Slide 13: Segment-wise Operating Performance
Segment-wise Operating Performance Quarterly Revenue Break-up (Rs. cr) YTD Revenue Break-up (Rs. cr) Q4 FY24 Q3 FY24 Q4 FY23 FY24 FY23 473 464 1,831 406 1,656 356 345 1,369 1,157 265 94 83 99 354 373 34 25 43 108 126 HPPC TSC AHN TOTAL HPPC TSC AHN TOTAL Shift (Y-o-Y) % 30.2% -5.1% -20.9% 16.5% Shif
Slide 14: Company Overview
Q4 FY24 Results Overview Company Overview Annexure 13
Slide 15: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 45+ 8* 354,100* 4* 34% 24% cumulative years of Manufacturing MTPA R&D Facilities Revenue CAGR % PAT CAGR % experience in the facilities Capacity Installed (FY19-23) (FY19-23) specialty chemicals industry Rossari – A Specialty-Chemical manufacturer prov
Slide 16: A 25-Year Journey of Transformation
A 25-Year Journey of Transformation Delivering Value and Maintaining Synergy Along the Way Looking back in time Our Company was initially incorporated as ‘Rossari Labtech’ in March, 2003, as a partnership firm. In the same year, in December, the name of the partnership firm was changed to ‘Rossari B
Slide 17: Business Overview
Business Overview One of the leading specialty chemicals manufacturer delivering differentiated & tailor-made solutions across Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health and Nutrition (AHN) businesses HPPC TSC AHN • One of the fastest-gr
Slide 18: Strengthening Market Presence
Strengthening Market Presence Increasingly tapping new segments across domestic and international markets Building direct Growing client touch-points with base of over several clients 1,000 customers Strong and both India and long-standing International relationships with several clients and distrib
Slide 19: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Manufacturing Facility at Silvassa • Located on 8.6 acres of land • Fungible manufacturing capabilities for powders, granules and liquids • Facility has a comprehensive range of testing & packaging capabilities • Effluent treatment facility, with 2,500 MT bulk stora
Slide 20: Growth Drivers
Growth Drivers 01 Augmenting product 02 Innovation and product 03 Seeding new business portfolio development lines • Enhance emphasis on green/sustainable • Strengthen innovation platform for • Evaluate opportunities based on existing solutions differentiated offerings capabilities and technical kno
Slide 21: Update on Key Subsidiaries
Update on Key Subsidiaries Executed synergistic acquisitions in the past complementing the ethos of Rossari’s business model Revenue (Rs. cr) CAGR – 20% • Unitop solutions sold across 25+ countries • Presence in high-potential Specialty chemical 651 554 454 Unitop Chemicals segments, such as Agroche
Slide 22: Key Synergies from Acquisitions
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Augmented Expansion of Extension of Pooling together of Inorganic presence in addressable manufacturing related technologies investments within Specialty Chemical, domestic and exp
Slide 23: Strategies: Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 1. Expanding into New Business Lines • Leverage existing R&D capabilities and expertise in core chemistries to • Diversified revenue streams, reduced risk from dependence on core diversify into new product segments. segments. • Exp
Slide 24: Strategies: Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 4. Enhancing Sustainability and Green Initiatives • Invest in research and development of advanced sustainable chemical • Strengthened brand reputation as an environmentally responsible solutions. company. • Explore opportunities i
Slide 25: Strategies: Responses to Threats
Strategies Strategic Responses to Threats Threats Outcomes 1. Increasing Competition • Entry of new players or intensified competition from existing rivals in the • Drive for innovation and development of differentiated products specialty chemicals market. • Improved operational efficiency and cost
Slide 26: Focus on Green & Sustainable Chemical Solutions since Inception
Focus on Green & Sustainable Chemical Solutions since Inception Specialists in producing environmentally-benign substitutes that replace legacy and harmful products Focus on green, sustainable and cost neutral products Minimizing carbon footprint of manufacturing processes while maximizing customer
Slide 27: Corporate Social Responsibility
Corporate Social Responsibility We at Rossari, recognize our role and responsibility to deliver superior and sustainable value to our customers, business partners, employees and communities. We have implemented various CSR initiatives with employee volunteers as well as in partnership with implement
Slide 28: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Founders & Promoters Independent Directors • B. Sc. (chemistry major) from K. J. Somaiya College of Science, • B. Com. from H. L. Commerce College, Gujarat University & associate member of ICAI University of Bombay & B. Sc. (technology) in textile chemist
Slide 29: Annexure
Q4 FY24 Results Overview Company Overview Annexure 28
Slide 30: Conference Call Details
CONFERENCE CALL DETAILS Q4 F Y 2024 Earnings C o n f er ence Call Time 04:00 PM IST on Tuesday, April 30, 2024 Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Diamond Pass Registration (cho
Slide 31: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvas
Slide 32: Thank you
Thank y#u